Gastric atrophy and gastric cancer: a meta-analytical assessment of risk and the influence of topographical distribution.
Eoghan Burke, Patricia Harkins, Mayilone Arumugasamy
✦ AI-curated · Sources linked
In 30 seconds
This meta-analysis evaluated the risk of gastric cancer associated with gastric atrophy in 21,006 patients across ten studies. It found a standardized incidence ratio of 20.7 (95% CI: 14.0-30.2) for gastric cancer in patients with gastric atrophy, highlighting a significantly higher risk with extensive atrophy compared to antral-predominant disease.
Key findings
- Standardized incidence ratio of gastric cancer in gastric atrophy was 20.7 (95% CI: 14.0-30.2).
- Extensive gastric atrophy showed a significantly higher risk compared to antral-predominant disease with a pooled odds ratio of 0.27.
- The study identified gaps in the Western evidence base regarding gastric atrophy and cancer risk.
Why it matters
Understanding the relationship between gastric atrophy and gastric cancer risk is crucial for developing effective surveillance strategies, particularly in low-incidence populations. This research underscores the need for tailored guidelines based on regional risk profiles.
What to keep in mind
Common limitations included inadequate distinction between gastric atrophy and intestinal metaplasia and methodological issues in several large European cohorts.